FDA establishment 3002616806, South Korea. Part of Daewoong Pharmaceutical's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, and the shipments FDA refused at the border.
FDA has posted no inspections for this site.
| Product | Charges | Latest |
|---|---|---|
| ONABOTULINUMTOXINAOther · 58PDZ05 | Oct 23, 2026 | |
| ONABOTULINUMTOXINAOther · 58PCK05 | Mar 24, 2025 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard, warning letters and enforcement reports
South Korea. Part of